Laser nanobubbles induce immunogenic cell death in breast cancer
Author:
Affiliation:
1. Department of Biomedical Engineering
2. The University of Texas at Austin
3. USA
4. Department of Electrical and Computer Engineering
5. Department of Chemistry and Biochemistry
6. Texas State University
Abstract
Laser nanobubbles induce dendritic cell activation in breast cancer cells.
Funder
Cancer Prevention and Research Institute of Texas
American Heart Association
U.S. Department of Defense
National Institutes of Health
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science
Link
http://pubs.rsc.org/en/content/articlepdf/2021/NR/D0NR06587K
Reference55 articles.
1. Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial
2. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
3. Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
4. Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
5. The future of immune checkpoint therapy
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enhanced drug delivery with nanocarriers: a comprehensive review of recent advances in breast cancer detection and treatment;Discover Nano;2024-09-07
2. Laser-induced vapor nanobubbles for B16-F10 melanoma cell killing and intracellular delivery of chemotherapeutics;Journal of Controlled Release;2024-01
3. Program and Abstracts;Tissue Engineering Part A;2023-06-01
4. Recent advances of nanobubble-based systems in cancer therapeutics: A Review;Biomedical Engineering Advances;2023-06
5. Promotion of ICD via Nanotechnology;Macromolecular Bioscience;2023-05-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3